PAS
HBIO icon

Point72 Asia (Singapore)’s Harvard Bioscience HBIO Stock Holding History

Point72 Asia (Singapore)’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$6.45K Sell
1,470
-1,254
-46% -$5.95K ﹤0.01% 807
2025
Q2 		$12.1K Buy
+2,724
New +$11.4K ﹤0.01% 784
2024
Q3 		– Sell
-166
Closed -$4.74K – 1128
2024
Q2 		$4.74K Buy
+166
New +$5.82K ﹤0.01% 970

Other funds holding HBIO

AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Point72 Asia (Singapore)'s HBIO Position: Q3 2025 in Review

Point72 Asia (Singapore) reduced its Harvard Bioscience (HBIO) stake by 46% in Q3 2025, selling an estimated $5.95K and leaving 1,470 shares worth $6.45K. The position accounts for ﹤0.01% of the portfolio, ranked #807.

Point72 Asia (Singapore) first reported a position in HBIO in Q2 2024 and has held it in 3 quarters since. The position peaked at $12.1K in Q2 2025. 59 funds tracked by Wall St. Rank hold HBIO as of Q3 2025.

  • Point72 Asia (Singapore) held 1,470 shares of Harvard Bioscience worth $6.45K as of Q3 2025.
  • Point72 Asia (Singapore) sold 1,254 Harvard Bioscience shares in Q3 2025, an estimated $5.95K.
  • Harvard Bioscience made up ﹤0.01% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #807 holding.
  • Point72 Asia (Singapore) first reported a position in Harvard Bioscience in Q2 2024 and has held it in 3 quarters since.
  • Point72 Asia (Singapore)'s Harvard Bioscience position peaked at $12.1K in Q2 2025.
  • 59 funds tracked by Wall St. Rank held Harvard Bioscience as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.